Can Intercalating Chemotherapy With Epidermal Growth Factor Receptor Inhibitors Delay Development of Treatment Resistance in Advanced Non-Small Cell Lung Cancer?
Expert Opinion on Pharmacotherapy - United Kingdom
doi 10.1080/14656566.2017.1409721
Full Text
Open PDFAbstract
Available in full text
Date
November 29, 2017
Authors
Publisher
Informa UK Limited